AnaptysBio, Inc. short interest in 2024
In 2024, AnaptysBio, Inc.'s disclosed short interest ran from 17.01% of shares outstanding on 12 Jan 2024 to 24.08% on 31 Dec 2024, a change of +7.07 percentage points. The year's high was 24.08% on 31 Dec 2024 and its low 15.45% on 15 Mar 2024, averaging 19.17% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 25.12 days on 12 Jan 2024. Full history: AnaptysBio, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 17.01% (12 Jan 2024)
- End of year
- 24.08% (31 Dec 2024)
- Change
- +7.07 pp
- High
- 24.08% (31 Dec 2024)
- Low
- 15.45% (15 Mar 2024)
- Average
- 19.17%
- Highest days to cover
- 25.12 (12 Jan 2024)
- SEC filings marked
- 9
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 17.01% | 25.12 | results (8-K) |
| 31 Jan 2024 | 19.25% | 15.21 | |
| 15 Feb 2024 | 16.95% | 22.46 | |
| 29 Feb 2024 | 15.81% | 15.79 | |
| 15 Mar 2024 | 15.45% | 11.30 | 10-K filed, results (8-K) |
| 28 Mar 2024 | 16.08% | 10.28 | |
| 15 Apr 2024 | 15.95% | 11.26 | |
| 30 Apr 2024 | 16.35% | 9.85 | |
| 15 May 2024 | 16.59% | 13.43 | 10-Q filed, results (8-K) |
| 31 May 2024 | 16.79% | 15.68 | |
| 14 Jun 2024 | 17.26% | 14.21 | |
| 28 Jun 2024 | 18.14% | 12.37 | |
| 15 Jul 2024 | 19.34% | 20.58 | |
| 31 Jul 2024 | 20.60% | 16.37 | |
| 15 Aug 2024 | 20.44% | 13.33 | 10-Q filed, results (8-K) |
| 30 Aug 2024 | 20.52% | 18.70 | |
| 13 Sep 2024 | 21.25% | 24.28 | |
| 30 Sep 2024 | 21.70% | 20.14 | |
| 15 Oct 2024 | 21.78% | 20.51 | |
| 31 Oct 2024 | 20.29% | 10.10 | |
| 15 Nov 2024 | 22.07% | 13.59 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 23.33% | 16.08 | |
| 13 Dec 2024 | 22.96% | 7.32 | |
| 31 Dec 2024 | 24.08% | 11.83 |
See also: AnaptysBio, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.